Nevro Corp. (NYSE:NVRO) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET
Company Participants
Julie Dewey - Corporate Communications and Investor Relations Officer
Keith Grossman - Chairman, Chief Executive Officer and President
Rod MacLeod - Chief Financial Officer
Conference Call Participants
Calvin Chu - Morgan Stanley
Simran Kaur - Piper Sandler
Robbie Marcus - JPMorgan
Danielle Antalffy - SVB Securities
Joanne Wuensch - Citi
Suraj Kalia - Oppenheimer
David Rescott - Truist Securities
Maggie Boeye - William Blair
Operator
Good afternoon. My name is Chris, and I'll be your conference operator today. At this time, I'd like to welcome everyone to Nevro's First Quarter 2022 Financial Results Conference Call. [Operator Instructions]
I would now like to turn the call over to Julie Dewey for introductory remarks. Please go ahead.
Julie Dewey
Good afternoon, and welcome to Nevro's First Quarter 2022 Earnings Conference Call. We appreciate you joining us. I'm Julie Dewey, Nevro's Chief Corporate Communications and IR Officer.
With me today are Keith Grossman, Chairman, CEO and President; and Rod MacLeod, Chief Financial Officer. The format of our call today will be a discussion of first quarter business results from Keith, followed by detailed financials and guidance from Rod, and then we'll open up the call for questions. Please note there are also slides available related to our first quarter performance on the Nevro Investor Relations website on the Events & Presentations page. Earlier today, Nevro released its financial results for the first quarter ended March 31, 2022. A copy of our earnings release is available on our Investor Relations section of our website at nevro.com. This call is being broadcast live over the Internet to all interested parties on May 4, 2022, and an archived copy of this webcast will be available on our Investor Relations website.
Before we begin, I'd like to remind everyone that comments made on today's call may include forward-looking statements within the meaning of federal securities laws. Our results could differ materially from those expressed or implied as a result of certain risks and uncertainties. Please refer to our SEC filings, including our Form 10-Q to be filed later today for a detailed presentation of risks. The forward-looking statements in this call speak only as of today, and we undertake no obligation to update or revise any of these statements.
In addition, we will refer to adjusted EBITDA, which is a non-GAAP measure that is used to help investors understand Nevro's ongoing business performance. Non-GAAP adjusted EBITDA excludes certain litigation expenses, interest, taxes and noncash items such as stock-based compensation and depreciation and amortization. Please refer to GAAP to non-GAAP reconciliation tables within our earnings release.